Blood Vessel Epicardial Substance (BVES) in junctional signaling and cancer

9Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Blood vessel epicardial substance (BVES) is a tight-junction associated protein that was originally discovered from a cDNA screen of the developing heart. Research over the last decade has shown that not only is BVES is expressed in cardiac and skeletal tissue, but BVES is also is expressed throughout the gastrointestinal epithelium. Mice lacking BVES sustain worse intestinal injury and inflammation. Furthermore, BVES is suppressed in gastrointestinal cancers, and mouse modeling has shown that loss of BVES promotes tumor formation. Recent work from multiple laboratories has revealed that BVES can regulate several molecular pathways, including cAMP, WNT, and promoting the degradation of the oncogene, c-Myc. This review will summarize our current understanding of how BVES regulates the intestinal epithelium and discuss how BVES functions at the molecular level to preserve epithelial phenotypes and suppress tumorigenesis.

Cite

CITATION STYLE

APA

Parang, B., Thompson, J. J., & Williams, C. S. (2018, October 2). Blood Vessel Epicardial Substance (BVES) in junctional signaling and cancer. Tissue Barriers. Taylor and Francis Inc. https://doi.org/10.1080/21688370.2018.1499843

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free